Results 131 to 140 of about 28,158 (213)
Carboxymethyl cellulose‐based biopolymer optical fibers are fabricated using aqueous wet spinning. The fibers exhibit record‐low optical attenuation in polysaccharide‐based waveguides while maintaining efficient transmission across the visible‐to‐near‐infrared region of the electromagnetic spectrum.
Jani Patrakka +3 more
wiley +1 more source
ABSTRACT Lignocellulosic residues are non‐cost, non‐edible, renewable feedstocks that can be used in polyhydroxybutyrate (PHB) production. PHB is a bioplastic synthetized by microorganisms, formed intracellularly under stressful growth conditions; however, its production costs are high, representing the major drawback for fossil‐based plastics ...
Clara Matte Borges Machado +8 more
wiley +1 more source
Recent Advances in Plastic Waste Biodegradation: Microorganisms, Enzymes, Invertebrates, and Evidence Standards. [PDF]
Phang KS, Chong CM, Chen Y, Loh JY.
europepmc +1 more source
ABSTRACT The rapid expansion of the global textile industry, driven by the fast‐fashion paradigm, which is characterized by low‐cost, short‐lived garments made from inexpensive synthetic fibers, has intensified environmental pressures through increased waste generation, resource depletion, microplastic pollution, and greenhouse gas emissions ...
Fares Al‐Ostoot +2 more
wiley +1 more source
Monitoring the Environmental Degradation of Biodegradable Mulch Films Using Py-GC-MS and a Multitechnique Analytical Approach. [PDF]
De Falco F +8 more
europepmc +1 more source
ABSTRACT The transition to sustainable lactic acid (LA) biomanufacturing necessitates a shift from first‐generation feedstocks toward residual biomass and low‐pH fermentation, eliminating the costly, waste‐intensive salt purification and acidification steps. This study presents a novel, two‐yeast strategy designed to valorize inulin, a fructose polymer
Riccardo Milanesi +4 more
wiley +1 more source
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga +2 more
wiley +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Varied Mulching Practices Modulate Soil Hydrothermal-Nutrient Regimes and Root Yield of Indigowoad Root in an Oasis. [PDF]
Zhou P +6 more
europepmc +1 more source
Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges
This figure illustrates various material strategies for neurovascularized bone regeneration, including electroactive scaffolds, ion‐loaded materials, drug delivery systems, surface modifications, cells/cell products, growth factors, and peptides. These approaches aim to synergistically promote the regeneration of neural, vascular, and bone tissues ...
Yixin Ma +8 more
wiley +1 more source

